7 recruiting, 1 unknown. 8 Phase 2, 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Recruiting 7, Unknown 1 |
| Phase 1 | 5 | Recruiting 4, Unknown 1 |
Follow Malignant Solid Tumors: new trials by email Literature Review of Malignant Solid Tumors trials Research Report on Malignant Solid Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TAK-505 in Adults With Solid Tumors TAK-505 - Malignant Solid Tumors | Phase 1 / Phase 2 | Recruiting | Takeda | 151 | 2026-05-11 | 2026-10-28 |
| A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors SHR-7787 Injection, SHR-1316 Injection, SHR-4849 Injection - Malignant Solid Tumors | Phase 2 | Recruiting | Shanghai Hengrui Pharmaceutical Co., Ltd. | 400 | 2025-12-23 | 2026-01-12 |
| A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors SHR-4298 Injection - Malignant Solid Tumors | Phase 1 / Phase 2 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 200 | 2025-12-03 | 2026-08-12 |
| A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors SHR-4849、SHR-1316、SHR-8068、BP102、carboplatin、cisplatin - Malignant Solid Tumors | Phase 2 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 120 | 2025-07-08 | 2026-03-03 |
| One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors JCXH-211 Intratumoral Injection Combined with Anti-PD-1 Antibody IV infusion - Malignant Solid Tumors | Phase 1 / Phase 2 | Recruiting | Immorna Biotherapeutics, Inc. | 72 | 2025-05-23 | 2026-11-05 |
| Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia Asciminib - Malignant Solid Tumors | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 40 | 2025-02-14 | 2026-11-02 |
| A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors SHR-1681 - Malignant Solid Tumors | Phase 1 / Phase 2 | Recruiting | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 300 | 2025-01-21 | 2026-01-09 |
| A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients T60c injection - Malignant Solid Tumors | Phase 1 / Phase 2 | Unknown | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 62 | 2023-10-01 | 2023-10-13 |
Carboplatin (1) · Cisplatin (1) · Etoposide (1) · asciminib (1)
Suzhou Suncadia Biopharmaceuticals Co., Ltd. (3) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Immorna Biotherapeutics, Inc. (1) · M.D. Anderson Cancer Center (1) · Shanghai Hengrui Pharmaceutical Co., Ltd. (1) · Takeda (1)
China (5) · United States (2)
Ghayas Issa, MD (1) · RuiHua Xu (1)